U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 184 books (1345 items)

1.
2.
Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin.

Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin.

Cardiff (UK): National Collaborating Centre for Cancer (UK); 2010 Jul. (NICE Clinical Guidelines, No. 104.)

3.
Non-Hodgkin's Lymphoma: Diagnosis and Management.

Non-Hodgkin's Lymphoma: Diagnosis and Management.

National Guideline Alliance (UK).

London: National Institute for Health and Care Excellence (NICE); 2016 Jul. (NICE Guideline, No. 52.)

4.
Addendum to Haematological Cancers: improving outcomes (update).

Addendum to Haematological Cancers: improving outcomes (update).

National Collaborating Centre for Cancer (UK).

London: National Institute for Health and Care Excellence (NICE); 2016 May.

5.
Neutropenic Sepsis: Prevention and Management of Neutropenic Sepsis in Cancer Patients.

Neutropenic Sepsis: Prevention and Management of Neutropenic Sepsis in Cancer Patients.

National Collaborating Centre for Cancer (UK).

London: National Institute for Health and Clinical Excellence (NICE); 2012 Sep. (NICE Clinical Guidelines, No. 151.)

7.
Bladder Cancer: Diagnosis and Management.

Bladder Cancer: Diagnosis and Management.

National Collaborating Centre for Cancer (UK).

London: National Institute for Health and Care Excellence (NICE); 2015 Feb. (NICE Guideline, No. 2.)

9.
Coeliac Disease: Recognition, Assessment and Management.

Coeliac Disease: Recognition, Assessment and Management.

London: National Institute for Health and Care Excellence (NICE); 2015 Sep. (NICE Guideline, No. 20.)

11.
Addendum to Clinical Guideline 164, Familial breast cancer.

Addendum to Clinical Guideline 164, Familial breast cancer.

London: National Institute for Health and Care Excellence (NICE); 2017 Mar. (Clinical Guideline Addendum, No. 164.1.)

12.
Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action.

Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action.

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action; Martinez RM, Osei-Anto HA, McCormick M, editors.

Washington (DC): National Academies Press (US); 2020 Sep 10.

14.
Suspected cancer: recognition and referral.

Suspected cancer: recognition and referral.

London: National Institute for Health and Care Excellence (NICE); 2023 Oct 24. (NICE Guideline, No. 12.)

16.
Early and locally advanced breast cancer: diagnosis and management.

Early and locally advanced breast cancer: diagnosis and management.

London: National Institute for Health and Care Excellence (NICE); 2024 Jan 16. (NICE Guideline, No. 101.)

17.
Addendum to Clinical Guideline 81, Advanced Breast Cancer.

Addendum to Clinical Guideline 81, Advanced Breast Cancer.

London: National Institute for Health and Care Excellence (NICE); 2017 Aug. (Clinical Guideline Addendum, No. 81.2.)

19.
Guidelines for the Management of Non-Transfusion-Dependent β-Thalassaemia [Internet]. 3rd edition.

Guidelines for the Management of Non-Transfusion-Dependent β-Thalassaemia [Internet]. 3rd edition.

Taher AT, Musallam KM, Cappellini MD.

Nicosia (Cyprus): Thalassaemia International Federation; 2023.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...